Not applicableLooking for participantsNCT05124886What this trial is testingGut Kidney Axis in Enteric HyperoxaluriaWho this might be right forEnteric Hyperoxaluria NYU Langone Health 80
Large-scale testing (Phase 3)Ended earlyNCT03847090What this trial is testingEstablishing the Safety and Efficacy of Reloxaliase in Patients With Enteric HyperoxaluriaWho this might be right forEnteric Hyperoxaluria Allena Pharmaceuticals 92
Early research (Phase 1)UnknownNCT05650112What this trial is testingSafety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric HyperoxaluriaWho this might be right forHealthyEnteric Hyperoxaluria Federation Bio Inc. 48
Testing effectiveness (Phase 2)Study completedNCT00587041What this trial is testingUse of Oral Probiotics to Reduce Urinary Oxalate ExcretionWho this might be right forNephrolithiasisHyperoxaluriaCrohn's Disease Mayo Clinic 40
Testing effectiveness (Phase 2)Ended earlyNCT04909723What this trial is testingSafety, Tolerability, and Pharmacodynamics of NOV-001 in Adult SubjectsWho this might be right forHealthy VolunteersEnteric Hyperoxaluria Novome Biotechnologies Inc 153
Not applicableStudy completedNCT03095885What this trial is testingA Pilot Study of Oxalate Absorption in Secondary HyperoxaluriaWho this might be right forSecondary HyperoxaluriaNephrolithiasisHyperoxaluria+1 more Allena Pharmaceuticals 22
Very early researchStudy completedNCT05377112What this trial is testingSafety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or Short-bowel SyndromeWho this might be right forEnteric Hyperoxaluria Synlogic 11
Testing effectiveness (Phase 2)Study completedNCT02547805What this trial is testingEvaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 DaysWho this might be right forSecondary HyperoxaluriaNephrolithiasisHyperoxaluria+2 more Allena Pharmaceuticals 66
Large-scale testing (Phase 3)Study completedNCT03456830What this trial is testingEvaluate ALLN-177 in Patients With Enteric HyperoxaluriaWho this might be right forEnteric Hyperoxaluria Allena Pharmaceuticals 115
Testing effectiveness (Phase 2)Study completedNCT03391804What this trial is testingStudy of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and HyperoxalemiaWho this might be right forEnteric HyperoxaluriaPrimary HyperoxaluriaHyperoxalemia Allena Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT02289755What this trial is testingEvaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With HyperoxaluriaWho this might be right forHyperoxaluriaNephrolithiasis Allena Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT01127087What this trial is testingOxazyme in Patients With HyperoxaluriaWho this might be right forHyperoxaluria Mayo Clinic 22
Early research (Phase 1)Study completedNCT00588120What this trial is testingEnteric Oxalate Absorption Study in Unclassified HyperoxaluriaWho this might be right forEnteric HyperoxaluriaHyperoxaluria Mayo Clinic 114
Early research (Phase 1)Study completedNCT04629170What this trial is testingSafety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric HyperoxaluriaWho this might be right forHealthyEnteric Hyperoxaluria Synlogic 77
Testing effectiveness (Phase 2)Study completedNCT02503345What this trial is testingEvaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney StonesWho this might be right forSecondary HyperoxaluriaNephrolithiasisKidney Stones+2 more Allena Pharmaceuticals 32
Not applicableLooking for participantsNCT02780297What this trial is testingProspective Research Rare Kidney Stones (ProRKS)Who this might be right forHyperoxaluriaCystinuriaDent Disease+2 more Mayo Clinic 220